This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Jul-Aug;28(4):123-5.

doi: 10.1007/s12664-009-0045-9.

Upper gastrointestinal promotility drugs: not all uniform?

Rita Brun, Braden Kuo

PMID: 19937420
DOI: 10.1007/s12664-009-0045-9

Editorial

Upper gastrointestinal promotility drugs: not all uniform?

Rita Brun et al. Indian J Gastroenterol. 2009 Jul-Aug.

. 2009 Jul-Aug;28(4):123-5.

doi: 10.1007/s12664-009-0045-9.

Authors

Rita Brun, Braden Kuo

PMID: 19937420
DOI: 10.1007/s12664-009-0045-9

No abstract available

PubMed Disclaimer

Comment on

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.
Nasr I, Rao SS, Attaluri A, Hashmi SM, Summers R. Nasr I, et al. Indian J Gastroenterol. 2009 Jul-Aug;28(4):136-42. doi: 10.1007/s12664-009-0048-6. Epub 2009 Nov 24. Indian J Gastroenterol. 2009. PMID: 19937173 Free PMC article. Clinical Trial.

Similar articles

[Prokinetic drugs in gastroenterology].
Galmiche JP, Bruley des Varannes S, Le Bodic L. Galmiche JP, et al. Gastroenterol Clin Biol. 1991;15(2 ( Pt 3)):T7-10. Gastroenterol Clin Biol. 1991. PMID: 2065903 Review. French. No abstract available.
Ion channels as targets for treatment of gastrointestinal motility disorders.
Farrugia G. Farrugia G. Eur Rev Med Pharmacol Sci. 2008 Aug;12 Suppl 1:135. Eur Rev Med Pharmacol Sci. 2008. PMID: 18924455 No abstract available.
Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
Camilleri M. Camilleri M. Clin Pharmacol Ther. 2012 Jan;91(1):44-59. doi: 10.1038/clpt.2011.261. Epub 2011 Nov 9. Clin Pharmacol Ther. 2012. PMID: 22071696 Review. No abstract available.
Drugs targeting functional bowel disorders: insights from animal studies.
Sanger GJ, Hicks GA. Sanger GJ, et al. Curr Opin Pharmacol. 2002 Dec;2(6):678-83. doi: 10.1016/s1471-4892(02)00228-x. Curr Opin Pharmacol. 2002. PMID: 12482730 Review.
5-HT receptors and visceral hypersensitivity - 2B or not 2B, that is the question?
Grundy D. Grundy D. Neurogastroenterol Motil. 2006 May;18(5):339-42. doi: 10.1111/j.1365-2982.2006.00777.x. Neurogastroenterol Motil. 2006. PMID: 16629859 No abstract available.

See all similar articles

References

1. Neurogastroenterol Motil. 2005 Dec;17(6):821-6 - PubMed
1. Aliment Pharmacol Ther. 2001 Mar;15(3):277-89 - PubMed
1. N Engl J Med. 1990 Apr 12;322(15):1028-31 - PubMed
1. Gastroenterol Hepatol (N Y). 2009 Jun;5(6):435-42 - PubMed
1. Am J Gastroenterol. 2006 Jun;101(6):1211-5 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer